## Mechanistic Overview
CSF Soluble TREM2 Fragment Ratio as Priming State Indicator starts from the claim that modulating TREM2/ADAM10/17 within the disease context of biomarkers can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview CSF Soluble TREM2 Fragment Ratio as Priming State Indicator starts from the claim that modulating TREM2/ADAM10/17 within the disease context of biomarkers can redirect a disease-relevant process. The original description re
## Mechanistic Overview
Integrated Multi-Analyte CSF Panel Combining YKL-40, sTREM2, and Neurogranin starts from the claim that modulating CHI3L1/TREM2/NRGN within the disease context of biomarkers can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview Integrated Multi-Analyte CSF Panel Combining YKL-40, sTREM2, and Neurogranin starts from the claim that modulating CHI3L1/TREM2/NRGN within the disease context of biomarkers can redirect a disease-relevan
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
TREM2Biomarkerbiomarkers
Convergent signals
TREM2 recurs across 2 selected hypotheses with aligned directionality in biomarker.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
6/11
dimensions won
CSF Soluble TREM2 Fragment Ratio as Prim
7/11
dimensions won
Integrated Multi-Analyte CSF Panel Combi
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.70
0.65
Evidence
0.58
0.68
Novelty
0.72
0.65
Feasibility
0.55
0.82
Impact
0.82
0.78
Druggability
0.88
0.70
Safety
0.85
0.85
Competition
0.70
0.72
Data
0.50
0.80
Reproducible
0.52
0.65
KG Connect
0.50
0.50
Score Breakdown
Dimension
CSF Soluble TREM2 Fragment Rat
Integrated Multi-Analyte CSF P
Mechanistic
0.700
0.650
Evidence
0.580
0.680
Novelty
0.720
0.650
Feasibility
0.550
0.820
Impact
0.820
0.780
Druggability
0.880
0.700
Safety
0.850
0.850
Competition
0.700
0.720
Data
0.500
0.800
Reproducible
0.520
0.650
KG Connect
0.500
0.500
Evidence
CSF Soluble TREM2 Fragment Ratio as Priming State Indicator
# Biomarker Hypotheses for Detecting Microglial Priming States
---
## Hypothesis 1: TSPO PET Kinetic Modeling for Priming State Discrimination
**Title:** Distinguishing primed from dystrophic micro...
Skeptic
# Critical Evaluation of Microglial Priming Biomarker Hypotheses
## Hypothesis 1: TSPO PET Kinetic Modeling
### Weak Links
**Specificity Crisis.** TSPO is expressed on microglia, astrocytes, endoth...
Domain Expert
# Feasibility Assessment: Microglial Priming Biomarkers
## Executive Summary
The debate identified a fundamental translational gap: even validated microglial targets remain therapeutically inaccessi...
# Biomarker Hypotheses for Detecting Microglial Priming States
---
## Hypothesis 1: TSPO PET Kinetic Modeling for Priming State Discrimination
**Title:** Distinguishing primed from dystrophic micro...
Skeptic
# Critical Evaluation of Microglial Priming Biomarker Hypotheses
## Hypothesis 1: TSPO PET Kinetic Modeling
### Weak Links
**Specificity Crisis.** TSPO is expressed on microglia, astrocytes, endoth...
Domain Expert
# Feasibility Assessment: Microglial Priming Biomarkers
## Executive Summary
The debate identified a fundamental translational gap: even validated microglial targets remain therapeutically inaccessi...